State Street Corp Arrowhead Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.47 Trillion
  • Q4 2024

A detailed history of State Street Corp transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 6,016,227 shares of ARWR stock, worth $83.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,016,227
Previous 6,354,331 5.32%
Holding current value
$83.1 Million
Previous $123 Million 8.06%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$17.7 - $26.34 $5.98 Million - $8.91 Million
-338,104 Reduced 5.32%
6,016,227 $113 Million
Q3 2024

Nov 14, 2024
BUY
$19.36 - $29.54 $10 Million - $15.3 Million
516,569 Added 8.85%
6,354,331 $123 Million
Q2 2024

Aug 14, 2024
SELL
$21.87 - $28.24 $15.8 Million - $20.4 Million
-722,941 Reduced 11.02%
5,837,762 $152 Million
Q1 2024

May 15, 2024
SELL
$27.21 - $39.48 $7.19 Million - $10.4 Million
-264,408 Reduced 3.87%
6,560,703 $188 Million
Q4 2023

Feb 14, 2024
BUY
$21.2 - $31.03 $20.4 Million - $29.9 Million
962,146 Added 16.41%
6,825,111 $209 Million
Q3 2023

Nov 14, 2023
BUY
$26.2 - $36.08 $9.31 Million - $12.8 Million
355,394 Added 6.45%
5,862,965 $158 Million
Q2 2023

Aug 14, 2023
SELL
$25.16 - $41.38 $9.94 Million - $16.4 Million
-395,197 Reduced 6.7%
5,507,571 $196 Million
Q1 2023

May 15, 2023
SELL
$23.68 - $38.51 $1.6 Million - $2.6 Million
-67,576 Reduced 1.13%
5,902,768 $150 Million
Q4 2022

Feb 14, 2023
BUY
$28.0 - $40.56 $20 Million - $29 Million
715,912 Added 13.62%
5,970,344 $242 Million
Q3 2022

Nov 15, 2022
SELL
$29.63 - $48.31 $9.73 Million - $15.9 Million
-328,314 Reduced 5.88%
5,254,432 $174 Million
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $25 Million - $45.6 Million
900,791 Added 19.24%
5,582,746 $197 Million
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $30.8 Million - $54.4 Million
777,184 Added 19.9%
4,681,955 $215 Million
Q4 2021

Feb 14, 2022
SELL
$58.09 - $82.51 $1.53 Million - $2.18 Million
-26,397 Reduced 0.67%
3,904,771 $259 Million
Q3 2021

Nov 15, 2021
BUY
$58.38 - $84.96 $20.1 Million - $29.3 Million
344,837 Added 9.62%
3,931,168 $245 Million
Q2 2021

Aug 16, 2021
SELL
$62.15 - $90.32 $9.19 Million - $13.3 Million
-147,789 Reduced 3.96%
3,586,331 $297 Million
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $12.1 Million - $17.9 Million
-197,895 Reduced 5.03%
3,734,120 $248 Million
Q4 2020

Feb 16, 2021
SELL
$43.82 - $85.37 $26.8 Million - $52.2 Million
-611,109 Reduced 13.45%
3,932,015 $302 Million
Q3 2020

Nov 10, 2020
SELL
$33.21 - $51.27 $11.6 Million - $17.9 Million
-348,323 Reduced 7.12%
4,543,124 $196 Million
Q2 2020

Aug 14, 2020
BUY
$26.12 - $43.27 $15.6 Million - $25.8 Million
596,773 Added 13.9%
4,891,447 $211 Million
Q1 2020

May 11, 2020
BUY
$20.56 - $63.12 $88.3 Million - $271 Million
4,294,674 New
4,294,674 $124 Million

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.46B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email